MedTrace Logo

Venlafaxine for Postoperative Pain of Laparoscopic Cholecystectomy

NCT05884268 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-06-01

No results posted yet for this study

Summary

Recent studies on the impact of perioperative venlafaxine for treatment of acute postoperative pain have yielded positive outcomes . The aim of the present study is to investigate the role of perioperative venlafaxine on the management of postoperative pain in patients undergoing LC.

Conditions

  • Laparoscopic Cholecystectomy

Interventions

DRUG

Venlafaxine

Patients scheduled for elective LC will receive 150 mg venlafaxine before surgery

DRUG

Placebo

Patients scheduled for elective LC will receive placebo venlafaxine before surgery

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-30
Primary Completion
2024-01-30
Completion
2024-01-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05884268 on ClinicalTrials.gov